Form 4: Orchestra BioMed Director Sells Shares for Tax Obligations Following RSU Vesting

Orchestra BioMed Holdings, Inc. Director Eric S. Fain sold 2,683 shares of common stock for $3.05 per share to cover tax obligations related to the vesting of restricted stock units.

Summary

• Eric S. Fain, a Director of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction on June 26, 2025.
• The transaction involved the disposition of 2,683 shares of Common Stock.
• The shares were sold at a weighted average price of $3.05 per share, with individual sales ranging from $2.98 to $3.11.
• The disposition was associated with tax obligations arising from the vesting of Restricted Stock Units (RSUs) that were granted on June 20, 2024.
• Following this transaction, Eric S. Fain beneficially owns 50,949 shares indirectly through the Fain Living Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a director selling shares can sometimes be viewed negatively, this specific transaction is explicitly stated to be for tax obligations related to RSU vesting, which is a routine and expected event. The vesting itself implies positive performance or tenure.

Positives

• The transaction indicates the vesting of Restricted Stock Units (RSUs) granted to the director, which typically occurs upon meeting performance milestones or time-based conditions, reflecting positively on the company's prior performance or tenure.

Negatives

• The sale of shares by a director, even for tax purposes, reduces their direct ownership in the company.

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation. Such transactions are common across all industries for executives and directors who receive Restricted Stock Units (RSUs) as part of their compensation, often requiring a portion of vested shares to be sold to cover tax liabilities.

Related Party Transactions

• The 50,949 shares beneficially owned following the transaction are held indirectly by the Fain Living Trust, indicating a related party holding.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in a director's direct ownership, but it is for a routine tax purpose and not indicative of a lack of confidence. The underlying RSU vesting is generally positive.
• Employees: No direct impact mentioned.

Key Dates

Keywords

Orchestra BioMed Holdings, OBIO, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU Vesting, Director Transaction, Equity Compensation, Tax Obligations